Effects of Multispecies Probiotic Combination on Helicobacter Pylori Infection in Vitro

Overview

Journal Clin Vaccine Immunol

Publisher American Society for Microbiology

Specialties Allergy & Immunology
Pathology

Date 2008 Jun 27

PMID 18579692

Citations 22

Authors

E Myllyluoma

A-M Ahonen

R Korpela

H Vapaatalo

E Kankuri

Affiliations

Soon will be listed here.

Abstract

Probiotic bacteria alleviate many gastrointestinal symptoms, but the current trend of combining bacteria for additional benefit may make their effects more complex. We characterize four probiotics and their combination in terms of pathogen adhesion, barrier function, cell death, and inflammatory response in Helicobacter pylori-infected epithelial cells. H. pylori-infected Caco-2 cells were pretreated with Lactobacillus rhamnosus GG, Lactobacillus rhamnosus Lc705, Propionibacterium freudenreichii subsp. shermanii Js, Bifidobacterium breve Bb99, or all four organisms in combination. We evaluated the adhesion of H. pylori by in situ immunofluorescence; epithelial barrier function by measurement of transepithelial resistance; apoptosis by measurement of caspase 3 activation; cell membrane leakage by measurement of lactate dehydrogenase release; and inflammation by measurement of interleukin-8 (IL-8), IL-10, prostaglandin E(2) (PGE(2)), and leukotriene B(4) (LTB(4)) release. All probiotics inhibited H. pylori adhesion. L. rhamnosus GG, L. rhamnosus Lc705, P. freudenreichii subsp. shermanii Js, and the combination inhibited H. pylori-induced cell membrane leakage. L. rhamnosus GG, L. rhamnosus Lc705, and the combination initially improved epithelial barrier function but increased the H. pylori-induced barrier deterioration after incubation for 24 to 42 h. L. rhamnosus GG, L. rhamnosus Lc705, and P. freudenreichii subsp. shermanii Js inhibited H. pylori-induced IL-8 release, whereas L. rhamnosus GG, L. rhamnosus Lc705, and B. breve Bb99 suppressed PGE(2) release. None of these anti-inflammatory effects persisted when the probiotics were used in combination. The combination thus increased the levels of IL-8, PGE(2), and LTB(4) released from H. pylori-infected epithelial cells. The proinflammatory actions of the individual components dominated the anti-inflammatory effects when the probiotic bacteria were used in combination. Our results stress that the therapeutic response can be optimized if probiotic strains are characterized before they are used in combination.

Citing Articles

Saccharomyces boulardii enhances anti-inflammatory effectors and AhR activation via metabolic interactions in probiotic communities.

Hedin K, Mirhakkak M, Vaaben T, Sands C, Pedersen M, Baker A ISME J. 2024; 18(1).

PMID: 39488793 PMC: 11631509. DOI: 10.1093/ismejo/wrae212.

Lyophilized cell-free supernatants of Limosilactobacillus fermentum T0701 exhibited antibacterial activity against Helicobacter pylori.

Sornsenee P, Surachat K, Wong T, Kaewdech A, Saki M, Romyasamit C Sci Rep. 2024; 14(1):13632.

PMID: 38871850 PMC: 11176309. DOI: 10.1038/s41598-024-64443-4.

Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation.

Raheem A, Liang L, Zhang G, Cui S Front Immunol. 2021; 12:616713.

PMID: 33897683 PMC: 8060567. DOI: 10.3389/fimmu.2021.616713.

Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.

Yu M, Zhang R, Ni P, Chen S, Duan G PLoS One. 2019; 14(10):e0223309.

PMID: 31577828 PMC: 6774518. DOI: 10.1371/journal.pone.0223309.

Invitro synergistic activity of lactic acid bacteria against multi-drug resistant staphylococci.

Bhola J, Bhadekar R BMC Complement Altern Med. 2019; 19(1):70.

PMID: 30890126 PMC: 6425562. DOI: 10.1186/s12906-019-2470-3.

References

Terres A, Pajares J, Hopkins A, Murphy A, Moran A, Baird A . Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect Immun. 1998; 66(6):2943-50. PMC: 108293. DOI: 10.1128/IAI.66.6.2943-2950.1998. View

Isolauri E, Kirjavainen P, Salminen S . Probiotics: a role in the treatment of intestinal infection and inflammation?. Gut. 2002; 50 Suppl 3:III54-9. PMC: 1867676. DOI: 10.1136/gut.50.suppl_3.iii54. View

Jan G, Haouzi D, Rouault A, Metivier D, Kroemer G, Brenner C . Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 2002; 9(2):179-88. DOI: 10.1038/sj.cdd.4400935. View

Mumy K, McCormick B . Events at the host-microbial interface of the gastrointestinal tract. II. Role of the intestinal epithelium in pathogen-induced inflammation. Am J Physiol Gastrointest Liver Physiol. 2005; 288(5):G854-9. DOI: 10.1152/ajpgi.00565.2004. View

Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O . Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol. 2004; 114(1):131-6. DOI: 10.1016/j.jaci.2004.03.036. View

Yan F, Polk D . Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002; 277(52):50959-65. PMC: 4006994. DOI: 10.1074/jbc.M207050200. View

Menard S, Candalh C, Bambou J, Terpend K, Cerf-Bensussan N, Heyman M . Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut. 2004; 53(6):821-8. PMC: 1774064. DOI: 10.1136/gut.2003.026252. View

Ma D, Forsythe P, Bienenstock J . Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun. 2004; 72(9):5308-14. PMC: 517478. DOI: 10.1128/IAI.72.9.5308-5314.2004. View

McCracken V, Chun T, Baldeon M, Ahrne S, Molin G, Mackie R . TNF-alpha sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp Biol Med (Maywood). 2002; 227(8):665-70. DOI: 10.1177/153537020222700817. View

10.

Tuomola E, Ouwehand A, Salminen S . The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol. 1999; 26(2):137-42. DOI: 10.1111/j.1574-695X.1999.tb01381.x. View

11.

Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot I . Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2003; 53(1):108-14. PMC: 1773918. DOI: 10.1136/gut.53.1.108. View

12.

Smoot D, Wynn Z, Elliott T, Allen C, Mekasha G, Naab T . Effects of Helicobacter pylori on proliferation of gastric epithelial cells in vitro. Am J Gastroenterol. 1999; 94(6):1508-11. DOI: 10.1111/j.1572-0241.1999.01134.x. View

13.

Bernet M, Brassart D, Neeser J, Servin A . Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol. 1993; 59(12):4121-8. PMC: 195875. DOI: 10.1128/aem.59.12.4121-4128.1993. View

14.

Servin A . Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004; 28(4):405-40. DOI: 10.1016/j.femsre.2004.01.003. View

15.

Felley C, Michetti P . Probiotics and Helicobacter pylori. Best Pract Res Clin Gastroenterol. 2003; 17(5):785-91. DOI: 10.1016/s1521-6918(03)00070-2. View

16.

Otte J, Podolsky D . Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004; 286(4):G613-26. DOI: 10.1152/ajpgi.00341.2003. View

17.

Marshall B, Warren J . Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1(8390):1311-5. DOI: 10.1016/s0140-6736(84)91816-6. View

18.

Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H . Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol. 2002; 32(2):105-10. DOI: 10.1111/j.1574-695X.2002.tb00541.x. View

19.

Forestier C, De Champs C, Vatoux C, Joly B . Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol. 2001; 152(2):167-73. DOI: 10.1016/s0923-2508(01)01188-3. View

20.

Fox J, Wang T . Helicobacter pylori--not a good bug after all. N Engl J Med. 2001; 345(11):829-32. DOI: 10.1056/NEJM200109133451111. View